CLINICAL_TRIALS
trial_result
· 2018-03-27
Clinical Trial Update: Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis [Phase 3]
Summary
A Phase 3 clinical trial update reports long-term effectiveness and safety data for CP-690,550 in rheumatoid arthritis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Arthritis, Rheumatoid | Phase 3 | Status: COMPLETED | Results posted: 2018-03-27